These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 323358)
21. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates. Bonavida B; Lebow LT; Bradley TP J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675 [TBL] [Abstract][Full Text] [Related]
22. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells. Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777 [TBL] [Abstract][Full Text] [Related]
23. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype. Sabapathy TK; Cheng Q; Hui KM Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974 [TBL] [Abstract][Full Text] [Related]
24. Murine lymphocyte alloantigens. I. The Ly-6 locus. Potter TA; McKenzie IF; Morgan GM; Cherry M J Immunol; 1980 Aug; 125(2):541-5. PubMed ID: 6156206 [TBL] [Abstract][Full Text] [Related]
25. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression. Hurwitz JL; McAndrew EC; Doherty PC J Immunol; 1986 Sep; 137(6):1757-63. PubMed ID: 2875109 [TBL] [Abstract][Full Text] [Related]
26. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype. Welsh RM; Haspel MV; Parker DC; Holmes KV J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199 [TBL] [Abstract][Full Text] [Related]
27. Asialo-GM1-positive T killer cells are generated in F1 mice injected with parental spleen cells. Knobloch C; Dennert G J Immunol; 1988 Feb; 140(3):744-9. PubMed ID: 2448375 [TBL] [Abstract][Full Text] [Related]
28. Blocking of cytotoxic T-cell function of MOLF/Ei mice by anti-Ly 35.1 monoclonal antibody. Mieno M; Udono H; Ikegami S; Tada N; Shiku H; Nakayama E Immunology; 1989 Nov; 68(3):431-3. PubMed ID: 2592017 [TBL] [Abstract][Full Text] [Related]
30. Regulation of cytotoxic lymphocyte responses in vitro by alloantigen-activated spleen cells. Truitt GA; Rich RR; Rich SS J Immunol; 1977 Jul; 119(1):31-7. PubMed ID: 874322 [TBL] [Abstract][Full Text] [Related]
31. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
32. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations. Schwartz A; Gershon RK J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894 [TBL] [Abstract][Full Text] [Related]
33. Activation of T lymphocytes through the Ly-6 pathway is defective in A strain mice. Malek TR; Shevach EM; Danis KM J Immunol; 1989 Jul; 143(2):439-45. PubMed ID: 2525586 [TBL] [Abstract][Full Text] [Related]
34. Accessory molecules involved in antigen-mediated cytolysis and lymphokine production by cytotoxic T lymphocyte subsets. I. Identification of functions for the T cell surface molecules Ly-6C and Thy-1. Johnson R; Lancki DW; Fitch FW J Immunol; 1993 Sep; 151(6):2986-99. PubMed ID: 8104217 [TBL] [Abstract][Full Text] [Related]
35. Loss of specificity in cytolytic T lymphocyte clones obtained by limit dilution culture of Ly-2+ T cells. Shortman K; Wilson A; Scollay R J Immunol; 1984 Feb; 132(2):584-93. PubMed ID: 6197466 [TBL] [Abstract][Full Text] [Related]
36. Activation of nonspecific killer cells by interleukin 2-containing supernatants. Teh HS; Yu M J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216 [TBL] [Abstract][Full Text] [Related]
37. Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. Cantor H; Boyse EA J Exp Med; 1975 Jun; 141(6):1376-89. PubMed ID: 1092798 [TBL] [Abstract][Full Text] [Related]
38. Identification of early stages of T lymphocyte development in the thymus cortex and medulla. Scollay R; Shortman K J Immunol; 1985 Jun; 134(6):3632-42. PubMed ID: 3886788 [TBL] [Abstract][Full Text] [Related]
39. Allospecific suppression without requirement for participation of Ly 2+ cells. Holán V; Mitchison NA Immunology; 1984 Mar; 51(3):469-75. PubMed ID: 6199292 [TBL] [Abstract][Full Text] [Related]
40. [A study of proliferative responses to host Ia antigens in fully allogeneic bone marrow chimeras in mice--sequential analysis of the reactivity and characterization of the cells involved in the response]. Iwabuchi K Hokkaido Igaku Zasshi; 1986 Nov; 61(6):869-82. PubMed ID: 3493963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]